Cambridge, United Kingdom

Hassan Mohammad

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 388(Granted Patents)


Location History:

  • Haslingfield, GB (1998 - 2013)
  • Littleport, GB (2013)
  • Ely, GB (2014 - 2017)
  • Cambridgeshire, GB (2017)
  • Cambridge, GB (2015 - 2019)

Company Filing History:


Years Active: 1998-2019

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):

Title: Innovations by Inventor Hassan Mohammad

Introduction

Hassan Mohammad is a notable inventor based in Cambridge, GB, recognized for his significant contributions to the pharmaceutical field. With a total of 17 patents to his name, he has made remarkable advancements in the treatment of pain and opioid-related conditions.

Latest Patents

Among his latest patents is a formulation involving hydromorphone and naloxone, aimed at treating pain and opioid bowel dysfunction syndrome. This invention focuses on prolonged release pharmaceutical dosage forms that include hydromorphone or its pharmaceutically acceptable salts, along with naloxone or its pharmaceutically acceptable salts. Another significant patent involves the manufacturing of active-free granules and tablets, which also pertain to prolonged release pharmaceutical dosage forms intended for human administration.

Career Highlights

Hassan has worked with prominent companies in the pharmaceutical industry, including Euro-Celtique S.A. and Purdue Pharma L.P. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Throughout his career, Hassan has collaborated with esteemed professionals such as Malcolm Walden and Geoffrey Gerard Hayes, enhancing the quality and impact of his inventions.

Conclusion

Hassan Mohammad's work exemplifies the spirit of innovation in the pharmaceutical industry, particularly in addressing critical health issues related to pain management and opioid use. His contributions continue to influence the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…